Details of the Drug Excipient

General Information of Drug Inactive Ingredient (DIG) (ID: E00651)

• DIG Name: Polyethylene glycol 300
• DIG Function: Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant

Full List of Drug(s) Co-administrated with This DIG

13 Approved Drug(s) Co-administrated with This DIG

Drug Name	Drug ID	Indication	Formulation Name	Formulation ID
Acetaminophen	DMUIE76	Allergic rhinitis [CA08.0]	Acetaminophen 500 mg tablet	F00373
Anastrozole	DMNP60F	Breast cancer [2C60-2C65]	Anastrozole 1 mg tablet	F01358
Aspirin	DM672AH	Acute coronary syndrome [BA41]	Aspirin 325 mg tablet	F01635
Bicalutamide	DMZMSPF	Prostate cancer [2C82.0]	Bicalutamide 50 mg tablet	F02523
Caffeine	DMKBJWP	Allergic rhinitis [CA08.0]	Caffeine 200 mg tablet	F03144
Diphenhydramine	DMKQTBA	Hyperemesis gravidarum []	Diphenhydramine 25 mg tablet	F06489
Escitalopram	DMFK9HG	Major depressive disorder [6A70.3]	Escitalopram 10 mg tablet	F07416
Gefitinib	DM15F0X	Colon adenocarcinoma []	Gefitinib 250 mg tablet	F09080
Halcinonide	DMGLAX1	Exanthem []	Halcinonide 0.1% solution	F23764
Ibuprofen	DM8VCBE	Dysmenorrhea [GA34.3]	Ibuprofen 200 mg tablet	F10135
Irbesartan	DMTP1DC	Diabetic kidney disease [GB61.Z]	Irbesartan 150 mg tablet	F10695
Oxymetazoline	DM8ZXT6	Arrhythmia [BC9Z]	Oxymetazoline 1% cream	F23856
Vandetanib	DMRICNP	Solid tumour/cancer [2A00-2F9Z]	Vandetanib 100 mg tablet	F22130